Friday, October 23, 2026

12:20 PM - 1:05 PM

Plenary / Clinical Innovation & Patient Impact Breakout Room

---

Overview

Sponsored by: CERULEA CLINICAL TRIALS

---

Details

Early‑phase trials set the trajectory of an asset’s entire development path. Decisions made at Phase I around design, endpoints, operations, and regulatory strategy can either unlock momentum or create downstream friction. This panel brings together perspectives from organisations with hands‑on experience delivering complex first‑in‑human and early phase clinical trials in Australia to examine the design choices that matter most. Through practical examples, speakers will discuss how early alignment across science, operations, and regulatory expectations can enable smoother progression into later‑phase and global development. The session will also explore why Australia is increasingly seen as a clinical trials partner, not just a location, offering the expertise, collaboration, and execution quality needed to translate cutting‑edge science into robust, globally credible programs. Sponsored by:

---

Speaker